Bottom line
What is STPAX's expense ratio?
STPAX's expense ratio is 2.82%, or about $282 a year on every $10,000 invested. That is more expensive than 99% of technology sector funds we track (median 0.75%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy.
Updated Dec 29, 2025
STPAX fee table
| Net expense ratio | 2.82% |
|---|---|
| Gross expense ratio | 2.82% |
| Management fee | 1.25% |
| Other expenses | 1.17% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Dec 29, 2025
What STPAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| STPAX | $844 | $1,399 | $1,978 | $3,541 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.82% expense ratio costs roughly $133,700 in lost growth, versus about $42,500 for the median technology sector fund (0.75%).